Sanofi and Sun Life Financial announced May 16 a new program that provides Canadians living with diabetes access to health information related to the use of Sanofi's Toujeo insulin pen.
The new digital initiative provides select Sun Life clients with tailored information and educational tips for using their insulin injection pen. The program launched in March 2018.
Canadians living with diabetes require varying levels of education, access to resources, and support depending on their personal situation or the stage of their diabetes. “This is why a tailored approach can be the best way for a person to obtain the information, support and tools needed to optimally manage their disease,” stated the companies in an announcement.
"Sanofi Canada's 100 year history began with the development of large-scale insulin production methods under Connaught Labs, now known as Sanofi Pasteur, and we are proud of our ongoing commitment to finding new and better solutions to helping those living with diabetes," said Niven Al-Khoury, President, Sanofi Canada. "We are excited to team up with Sun Life Financial in the important mission to provide education and raise greater awareness about this disease, with the goal of one day getting diabetes under control for all Canadians."